OCEANYX DRUG DISCOVERY PLATFORM

Oceanyx technology platform evaluates chemical properties of marine cyanobacterial genome through a “high content” functional genomics screening program to develop novel drug candidates for various therapeutic indications. 

It also uses these new chemical entities (NCEs) to identify novel drug targets. The Company leverages the marine cyanobacteria as its source for novel drugs and has already identified some lead candidates for the treatment of cancer, bone disorders, fibrosis and ophthalmic diseases.

Drug-Discovery-Process